Who Paid My Doc
Synagis
Drug Immunology
NDC 60574-4113-1
General payments
$1,317,906
Research payments
$0
Through program year 2024, $1,317,906 in general payments and $0 in research payments were reported against Synagis (Immunology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $91,261 | 1,793 |
| 2023 | General | $256,439 | 5,550 |
| 2022 | General | $153,977 | 5,586 |
| 2021 | General | $103,003 | 4,092 |
| 2020 | General | $221,626 | 2,651 |
| 2019 | General | $491,600 | 6,080 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 54 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 44 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
25,752 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.